SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-18-015883
Filing Date
2018-03-29
Accepted
2018-03-29 16:11:51
Documents
11
Period of Report
2018-05-15
Effectiveness Date
2018-03-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A s002112x1_def14a.htm DEF 14A 1798379
2 coachtemplate_chair.gif GRAPHIC 135
3 coachtemplate_check.gif GRAPHIC 141
4 coachtemplate_ex.gif GRAPHIC 88
5 coachtemplate_member.gif GRAPHIC 127
6 logo_footerprothena.jpg GRAPHIC 6866
7 logo_prothena.jpg GRAPHIC 18202
8 s002112x1_piechart-c.jpg GRAPHIC 120005
9 s002112x1_proxycard01.jpg GRAPHIC 1515981
10 s002112x1_proxycard02.jpg GRAPHIC 1630053
11 sig_yvonnemtchrakian.jpg GRAPHIC 14350
  Complete submission text file 0001140361-18-015883.txt   6112575
Mailing Address ADELPHI PLAZA UPPER GEORGE'S STREET DUN LAOGHAIRE, CO. DUBLIN L2 A96 T927
Business Address ADELPHI PLAZA UPPER GEORGE'S STREET DUN LAOGHAIRE, CO. DUBLIN L2 A96 T927 011-353-1-236-2500
Prothena Corp plc (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35676 | Film No.: 18723090
SIC: 2834 Pharmaceutical Preparations